Surgery Partners (SGRY) closed the last trading session at $25.55, gaining 0.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $40.25 indicates a 57.5% upside potential.The mean estimate comprises 12 short-term price targets with a standard deviation of $5.99. While the lowest estimate of $31 indicates a 21.3% increase from the current price level, the most optimistic analyst expe ...